Listeria Meningitis During Cefazolin Therapy
Authors: BENNETT LORBER
Journal: Annals of Internal Medicine (1975)

Letters1 February 1975Listeria Meningitis During Cefazolin TherapyBENNETT LORBER, M.D., JEROME SANTORO, M.D., ROBERT M. SWENSON, M.D.BENNETT LORBER, M.D., JEROME SANTORO, M.D., ROBERT M. SWENSON, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-82-2-226_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSuboptimal response of meningitis to cephalothin therapy (1-2) and actual development of meningitis during cephalothin therapy (3) have been reported. We recently observed a patient who developed meningitis due to Listeria monocytogenes while he was being treated with the new cephalosporin antibiotic, cefazolin.A 31-year-old Egyptian man with systemic lupus erythematosus and biopsy-proved lupus nephritis of the membranoproliferative type was admitted on 16 September 1974 with nephrotic syndrome and renal failure. He was treated with high dose prednisone, intermittent peritoneal dialysis, and after 10 days of hospitalization he was started on a course of nitrogen mustard. On 22 October 1974...References1. SOUTHERNSANFORD PJ: Meningococcal meningitis—suboptimal response to cephalothin therapy. N Engl J Med 280:1163-1165, 1969 CrossrefMedlineGoogle Scholar2. ALMOND H: Meningococcal infection unresponsive to cephalothin. N Engl J Med 281:218-219, 1969 CrossrefMedlineGoogle Scholar3. MANGIKUNDARGIQUINTILIANI RRR: Development of meningitis during cephalothin therapy. Ann Intern Med 78:347-351, 1973 LinkGoogle Scholar4. BAKERHINTHORNROMIG LDD: Penetration of cefazolin into CSF (abstract 410), in Program and Abstracts of the 14th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September 1974. Washington, D.C, American Society for Microbiology, 1974 Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Department of Medicine Section of Infectious Diseases Temple University Health Sciences Center Philadelphia, Pennsylvania 19140 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPopulation structure-guided profiling of antibiotic resistance patterns in clinical Listeria monocytogenes isolates from Germany identifies pbpB3 alleles associated with low levels of cephalosporin resistanceListeria monocytogenesListeria monocytogenes Cholecystitis: A Possible New SyndromeListeria monocytogenesListeria monocytogenesPost-Colonoscopic Listeria Septicemia in Ulcerative Colitis during Immunosuppressive TherapyCentral Nervous System Infection with Listeria monocytogenes : 33 Years' Experience at a General Hospital and Review of 776 Episodes from the LiteratureManagement of listeriosisAntimicrobial chemotherapy of human infection due toListeria monocytogenesIn vitro susceptibility of Listeria monocytogenes isolated from human blood and cerebrospinal fluidPenetration of Antimicrobial Drugs into the Cerebrospinal Fluid — Its Relevance in Postoperative CSF InfectionsDrugs Five Years Later CefazolinRICHARD QUINTILIANI, M.D., CHARLES H. NIGHTINGALE, Ph.D.Pharmacological Study of Cefazolin During Intermittent and Continuous Infusion: a Crossover Investigation in HumansInfectious Disease: An Annotated Bibliography of Recent Literature References to Journal Articles and Other PapersTreatment of Pasteurella multocida meningitisListeriosis 1 February 1975Volume 82, Issue 2Page: 226-226KeywordsAntibioticsHospitalizationsLupus erythematosusLupus nephritisMeningitisPeritoneal dialysisRenal failure Issue Published: 1 February 1975 PDF downloadLoading ...